Interleukin-6: an overview - PubMed (original) (raw)

Review

Interleukin-6: an overview

J Van Snick. Annu Rev Immunol. 1990.

No abstract available

PubMed Disclaimer

Similar articles

• [Interleukin-6 and its receptor].
  Matsuda T, Hirano T. Matsuda T, et al. Tanpakushitsu Kakusan Koso. 1991 May;36(7):1184-94. Tanpakushitsu Kakusan Koso. 1991. PMID: 1908108 Japanese. No abstract available.
• Interleukin-6 receptor and signals.
  Taga T, Hibi M, Murakami M, Saito M, Yawata H, Narazaki M, Hirata Y, Sugita T, Yasukawa K, Hirano T, et al. Taga T, et al. Chem Immunol. 1992;51:181-204. Chem Immunol. 1992. PMID: 1533128 Review. No abstract available.
• [Cytokines and receptors--their functions, structures and cloning of code genes. Functional polymorphism of BSF-2/IL-6 and its abnormal expression].
  Hirano T, Taga T, Matsuda T, Horii Y, Tang B, Kawanishi Y, Suematsu S, Kishimoto T. Hirano T, et al. Nihon Rinsho. 1988 May;46(5):1029-35. Nihon Rinsho. 1988. PMID: 3261809 Japanese. No abstract available.
• [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-1].
  Onozaki K. Onozaki K. Nihon Rinsho. 1988 May;46(5):994-1001. Nihon Rinsho. 1988. PMID: 2970559 Japanese. No abstract available.
• An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.
  Greene WC. Greene WC. Cancer Invest. 1987;5(4):369-76. Cancer Invest. 1987. PMID: 2889515 Review. No abstract available.

Cited by

• Mass transport effects in suspended waveguide biosensors integrated in microfluidic channels.
  Murthy CR, Armani AM. Murthy CR, et al. Sensors (Basel). 2012 Oct 25;12(11):14327-43. doi: 10.3390/s121114327. Sensors (Basel). 2012. PMID: 23202163 Free PMC article.
• Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer.
  Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Furuse J, Inagaki M, Higashi S, Kato H, Terao K, Ochiai A. Mitsunaga S, et al. Br J Cancer. 2013 May 28;108(10):2063-9. doi: 10.1038/bjc.2013.174. Epub 2013 Apr 16. Br J Cancer. 2013. PMID: 23591198 Free PMC article. Clinical Trial.
• Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
  Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. Kelesidis T, et al. Clin Infect Dis. 2015 Aug 15;61(4):651-60. doi: 10.1093/cid/civ327. Epub 2015 Apr 22. Clin Infect Dis. 2015. PMID: 25904376 Free PMC article. Clinical Trial.
• Interleukin-6 signals activating junB and TIS11 gene transcription in a B-cell hybridoma.
  Nakajima K, Wall R. Nakajima K, et al. Mol Cell Biol. 1991 Mar;11(3):1409-18. doi: 10.1128/mcb.11.3.1409-1418.1991. Mol Cell Biol. 1991. PMID: 1705005 Free PMC article.
• Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.
  Liu B. Liu B. AAPS J. 2006 Sep 29;8(3):E606-21. doi: 10.1208/aapsj080369. AAPS J. 2006. PMID: 17025278 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database